Therapy-related acute myeloid leukemia following treatment with trabectedin for Ewing's sarcoma

Acta Haematol. 2011;126(2):76-8. doi: 10.1159/000324936. Epub 2011 Apr 18.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents, Alkylating / adverse effects*
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / radiotherapy
  • Dioxoles / adverse effects*
  • Dioxoles / therapeutic use
  • Etoposide / adverse effects
  • Etoposide / therapeutic use
  • Fatal Outcome
  • Female
  • Gene Deletion
  • Gene Rearrangement
  • Humans
  • Leukemia, Myeloid, Acute / genetics*
  • Myeloid-Lymphoid Leukemia Protein / genetics
  • Neoplasms, Second Primary / genetics*
  • Sarcoma, Ewing / drug therapy*
  • Sarcoma, Ewing / radiotherapy
  • Tetrahydroisoquinolines / adverse effects*
  • Tetrahydroisoquinolines / therapeutic use
  • Topoisomerase Inhibitors
  • Trabectedin
  • Young Adult

Substances

  • Antineoplastic Agents, Alkylating
  • Dioxoles
  • Tetrahydroisoquinolines
  • Topoisomerase Inhibitors
  • Myeloid-Lymphoid Leukemia Protein
  • Etoposide
  • Trabectedin